Effects of Selegiline in a retroviral rat model for neurodegenerative disease

References

• Baszler T V, Zachary J F. Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection. Lab Invest 1990; 63: 612–623
   Google Scholar
• Bell J E, Donaldson Y K, Lowrie S, McKenzie C A, Elton R A, Chiswick A, Brettle R P, Ironside J W, Simmonds P. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996; 10: 493–499
   PubMed Web of Science ®Google Scholar
• Biagini G, Frasoldati A, Fuxe K, Agnati L F. The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes. Neurochem Int 1994; 25: 17–22
   Google Scholar
• Biagini G, Zoli M, Fuxe K, Agnati L F. L-deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain. Neuro Report 1993; 4: 955–958
   Google Scholar
• Brinkmann R, Schwinn A, Narayan O, Zink C, Kreth H, Roggendorf W, Dörries R, Schwender S, Imrich H, ter Meulen V. Human immunodeficiency virus in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol 1992; 31: 361–365
   Google Scholar
• Czub M, Czub S, Rappold M, Mazgareanu S, Schwender S, Demuth M, Hein A, Dörries R. Murine leukemia virus induced neurodegeneration of rats: enhancement of neuropathogenicity correlates with enhanced viral tropism for macrophages, microglia, and brain vascular cells. Virology 1995; 214: 239–244
   Google Scholar
• Czub M, McAttee F J, Portis J L. Murine retrovirus-induced spongiform encephalopathy: host and viral factors which determine the length of the incubation period. J Virol 1992; 66: 3298–3305
   Google Scholar
• Czub S, Lynch W P, Czub M, Portis J L. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab Invest 1994; 70: 711–723
   Google Scholar
• Czub S, Müller J G, Czub M, Müller-Hermelink H-K. Nature and sequence of simian immunodeficiency virus-induced central nervous system lesions: a kinetic study. Acta Neuropathol 1996; 92: 487–498
   Google Scholar
• Davies J, Everall I P, Weich S, McLaughlin J, Scaravilli F, Lantos P L. HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS 1997; 11: 1145–1150
   PubMed Web of Science ®Google Scholar
• Gerlach M, Youdim M BH, Riederer P. Pharmacology of Selegiline. Neurology 1996; 47: S137–S145
   PubMed Web of Science ®Google Scholar
• Heikkila R E, Manzino L, Cabbat F S, Duvoisin R C. Protection against dopaminergic neurotoxicity of 1-methyl-4-phenyl-l,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 1984; 311: 467–469
   PubMed Web of Science ®Google Scholar
• Hein A, Czub S, Xiao L X, Schwender S, Dömes R, Czub M. Effects of adoptive immune transfers on murine leukemia virus-infection of rats. Virology 1995; 211: 408–417
   Google Scholar
• Ju W Y, Holland D P, Tatton W P. (-)-Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats. Exp Neurol 1994; 126: 233–246
   PubMedGoogle Scholar
• Kay D G, Gravel C, Robitaille Y, Jolicoeur P. Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc Natl Acad Sci USA 1991; 88: 1281–1285
   Google Scholar
• Knoll J. The pharmacological basis of the therapeutic effect of (-)-deprenyl in age-related neurological diseases in inhibition of monoamine oxidase B. Inhibitors of Monoamino Oxidase B: Pharmacology and Clinical Use in Neurodegenerative Disorders, I Szelenyi. Birkhäuser Verlag, BaselSwitzerland 1993; 145–168
   Google Scholar
• Koenig S, Gendelman H E, Orenstein J M, DalCanto M C, Pezeshkpour G H, Yungblut M, Janotta F, Aksamit A, Martin M A, Fauci A S. Detection of AIDS virus in macrophages in brain tissues from AIDS patients with encephalopathy. Science 1986; 233: 1089–1093
   PubMed Web of Science ®Google Scholar
• Langston J W, Irwin I, Langston E B, Forno L S. Pargylin prevents l-methyl-4-phenyl-1,2,5,6-tetrahy-dropyridine-induced Parkinsonism in primates. Science 1984; 225: 1480–1482
   PubMed Web of Science ®Google Scholar
• Lassmann H, Zimprich F, Vass K, Hickey W F. Microglial cells are a component of the perivascular glia limitans. J Neurosci Res 1991; 28: 236–243
   PubMedGoogle Scholar
• Lynch W P, Czub S, McAttee F J, Hayes S F, Portis J L. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 1991; 7: 365–379
   PubMed Web of Science ®Google Scholar
• Lynch W P, Portis J L. Murine retrovirus-induced spongiform encephalopathy: disease expression is dependent on postnatal development of the central nervous system. J Virol 1993; 67: 2601–2610
   Google Scholar
• Lynch W P, Robertson S J, Portis J L. Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retro-virus-infected microglia. J Virol 1995; 69: 1408–1419
   PubMed Web of Science ®Google Scholar
• Martinez A, Sell M, Mitrovics T, Stoltenburg-Didinger G, Iglesias-Rozas J, Giraldo-Velasques M, Gosztonyi G, Cervos-Navarro J. The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases. Path Res Pract 1995; 191: 427–443
   PubMedGoogle Scholar
• Masliah E, Ge N, Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 1996; 10: 57–67
   PubMedGoogle Scholar
• McArthur J C, McClernon D R, Cronin M F, Nance-Sproson T E, Saah A J, St Clair M, Lanier E R. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42: 689–698
   PubMed Web of Science ®Google Scholar
• McMaster W R, Williams A F. Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol 1979; 9: 426–433
   PubMed Web of Science ®Google Scholar
• Myllylä V V, Sotaniemi K, Mäki-Ikola O, Rinne U K, Heinonen E H. Role of Selegiline in combination therapy of Parkinson's disease. Neurology 1996; 47: S200–S209
   Google Scholar
• Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C. CSF, plasma viral load and HIV associated dementia. J Neurovirol 1998; 4: 90–94
   Web of Science ®Google Scholar
• Robertson S J, Hasenkrug K J, Chesebro B, Portis J. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J Virol 1997; 71: 5287–5294
   PubMed Web of Science ®Google Scholar
• Salonen T, Haapalinna A, Heinonen E, Suhonen J, Hervonen A. Monoamine oxidase B inhibitor Selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity. Acta Neuropathol 1996; 91: 466–474
   Google Scholar
• Sano M, Ernesto C, Thomas R G, Klauber M R, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman C W, Pfeiffer E, Schneider L S, Thal L J. A controlled trial of Selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336: 1216–1222
   PubMed Web of Science ®Google Scholar
• Semkova I, Wolz P, Schilling M, Krieglstein J. Selegiline enhances NGF synthesis and protects central nervous system (CNS) neurons from excitotoxic and ischemic damage. Eur J Pharmacol 1996; 315: 19–30
   PubMed Web of Science ®Google Scholar
• Tatton W G, Chalmers-Redman R ME. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology 1996; 47: S171–S183
   Web of Science ®Google Scholar
• ThyagaRajan S, Felten S Y, Felten D L. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J Neuroimmunol 1998; 81: 144–157
   Google Scholar
• Tipton K F, Singer T P. The biochemical assay for monoamine oxidase activity: problems and pitfalls. Biochem Pharmacol 1993; 46: 1311–1316
   Google Scholar
• Wiley C A, Schrier R D, Nelson J A, Lampert P W, Oldstone M BA. Cellular localization of human immunodeficiency virus infection within the brains of Acquired Immune Deficiency Syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089–7093
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu P H. Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl. Brain Res Bull 1995; 38: 307–311
   Google Scholar